The hospital chain’s shares traded between $2.00 and $2.12 on July 23 and were down 2.9 percent from the day prior at market close. During the past year, CHS shares have traded between $2.00 and $5.35.
CHS is scheduled to release results for the second quarter of 2019 on Aug. 5. The company ended the first quarter of this year with net loss of $118 million on revenues of $3.38 billion. That’s compared to the first quarter of 2018, when CHS reported a net loss of $25 million on revenues of $3.69 billion.
More articles on healthcare finance:
4 health systems team up to save Philadelphia hospital
Cook County Health’s Dr. John Jay Shannon: Impending Medicaid DSH cuts are ‘immoral’
Harvard: Children’s health programs pay for themselves over time
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
